Wednesday, May 06, 2026 9:22:14 AM
Fantastic news out today and crickets.... very strange even for Ihub
Bullish
Recent ERNA News
- Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 • GlobeNewswire Inc. • 05/11/2026 01:15:00 PM
- Ernexa Therapeutics (ERNA) Preclinical Data Shows 100% Survival and Complete Tumor Clearance in Ovarian Cancer Models • IH Market News • 05/06/2026 02:40:59 PM
- Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models • GlobeNewswire Inc. • 05/06/2026 12:33:00 PM
- Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split • GlobeNewswire Inc. • 04/30/2026 01:00:00 PM
- Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026 • GlobeNewswire Inc. • 03/31/2026 12:55:00 PM
- Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series • GlobeNewswire Inc. • 02/20/2026 02:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 10:10:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/10/2026 01:42:27 PM
- Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering • GlobeNewswire Inc. • 02/06/2026 02:25:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/06/2026 05:15:15 AM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 02/05/2026 04:33:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2026 02:46:33 PM
- Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA • GlobeNewswire Inc. • 02/03/2026 01:45:00 PM
- Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program • GlobeNewswire Inc. • 01/27/2026 01:45:00 PM
- Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer • GlobeNewswire Inc. • 01/06/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 01:31:07 PM
- Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG • GlobeNewswire Inc. • 12/02/2025 01:50:00 PM
- Ernexa Therapeutics to Present at Oxford Global’s Cell 2025 • GlobeNewswire Inc. • 11/11/2025 12:00:00 PM
- Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials • GlobeNewswire Inc. • 11/10/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:30:52 PM

